Hans Nissbrandt

The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors

Suzanne L. Dickson, Rozita H. Shirazi, Caroline Hansson et al. · Journal of Neuroscience · 2012 · 389 citations · Full text

l‐DOPA‐induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of dyskinesia

Hanna Lindgren, Daniel Andersson, Sören Lagerkvist et al. · Journal of Neurochemistry · 2009 · 263 citations · Full text

Neurophysiology, Medicine, Parkinson Disease +15

Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism

Veronica Francardo, Francesco Bez, Tadeusz Wieloch et al. · Brain · 2014 · 195 citations · Full text

Sigma-1 Receptors, Neurotransmitter, Pharmacological Stimulation +17

The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine

Ola Blomqvist, Jörgen A. Engel, Hans Nissbrandt et al. · European Journal of Pharmacology · 1993 · 189 citations

Molecular Pharmacology, Substance Abuse, Mesolimbic Dopamine-activating Properties +11

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease

Veronica Francardo, Alessandra Recchia, Nataljia Popovic et al. · Neurobiology of Disease · 2011 · 173 citations · Full text

Motor Impairment, 6-Hydroxydopamine Mouse Model, Parkinson Disease +9